SMi is proud to announce the 12th annual Controlled Release conference will be taking place on 20 – 21 April 2015 in London, UK. Registration is now live.

LONDON, ENGLAND, UNITED KINGDOM, December 4, 2014 /EINPresswire.com/ -- Registration is now underway for the 12th annual Controlled Release Conference. The event is set to explore the latest developments in oral and ocular drug delivery, addressing alternative pathways for controlled release delivery and how to overcome assessment and formulation challenges.

With a strong international focus and leading industry innovators, SMi is pleased to announce that Professor Abla Creasey, Senior Scientific Director, Primary Container & Drug Delivery Systems/PDM, Janssen, will explore Implantable & Injectable Drug Delivery Technologies for extended release of small and large molecules, looking at the following areas:

• Hydrogel based sustained delivery of protein therapeutics and vaccines
• Biodegradable and customizable polymeric drug delivery systems
• Affinity peptide matrix for controlled delivery of protein therapeutics
• Polymeric depots for delivery of drug combinations

KEY PRESENTATION HIGHLIGHTS INCLUDE:

• Spotlight on innovations in oral drug delivery systems
• Learn how to achieve optimal parenteral drug delivery outcomes
• Discover new and novel platforms to overcome the challenges of long term drug delivery
• Examine how GlaxoSmithKline are achieving successes in ocular delivery over a long period of time

OTHER KEY SPEAKERS INCLUDE:

• Dr Ian Catchpole, Senior Investigator BioPharm Innovation, GlaxoSmithKline
• Professor Howard Stevens, Emeritus Professor, University of Strathclyde
• Dr Daniel Schweizer, PhD, Functional Lead, Technical Research & Development, Biologics Process R&D,Pharmaceutical Development, Novartis AG
• Teófilo Vasconcelos, Senior Formulation Scientist - Pharmaceutical Development, R&D Department, Bial
• Dr Morten Allesø, Principal Pharmaceutical Researcher, Biologics and Pharmaceutical Science, H. LundbeckA/S
• Dr Sabine May, Scientific Assistant, Boehringer Ingelheim Pharma
• Mark Wilson, Director, Collaboration Management, Europe, Platform Technology and Science, GlaxoSmithKline

Book before 19th December and save £400

For more information or to register please visit www.smi-online.co.uk/2015controlledrelease37.asp

Alternatively, contact Kinga Gradalska on +44 (0) 20 7827 6192 or email: kgradalska@smi-online.co.uk

--- END ---

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Margaret Mugema
SMi Group Ltd
+44 (0) 20 7827 6072
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.